An untreated gout flare typically peaks within the first 24 to 48 hours and then gradually subsides over seven to fourteen days. With appropriate anti-inflammatory treatment started early, meaningful swelling reduction can begin within hours, and many people see the worst of it resolve in three to five days. But the answer depends heavily on what you do about the flare, how long you’ve had gout, and whether urate crystals have been building up in the joint over months or years.
How Quickly Medications Bring Swelling Down
The main drugs used to treat an acute gout flare are colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs like naproxen or indomethacin), and corticosteroids. Each works on a different timeline. Low-dose colchicine can provide meaningful pain relief as early as 16 hours after the first dose, which is faster than NSAIDs commonly prescribed for gout, where significant pain reduction has been shown at 48 hours at the earliest.1ACR Meeting Abstracts. Colchicine As Assessed by Target Joint Pain Scores Is Effective at 16 Hours in Patients with Acute Gout Flares A Cochrane review found that high-dose colchicine roughly doubled the rate of treatment success at 32 to 36 hours compared with placebo, and inflammation was reduced in about half the patients by that time point.2PubMed Central. Colchicine for acute gout The catch with high-dose colchicine is that side effects, mainly gastrointestinal, jump dramatically. Low-dose colchicine works nearly as well for pain with far fewer problems.
Corticosteroids, whether taken by mouth or injected directly into the joint, tend to work on a similar timeline as NSAIDs. Most people notice a clear reduction in swelling within two to three days, with the flare resolving fully over a week or so. Joint injection can be faster for a single affected joint because the drug goes right where it’s needed.
For people who can’t tolerate standard treatments or whose flares don’t respond, a newer class of drugs that block the inflammatory signal interleukin-1 (IL-1) can speed things up. In a systematic review comparing IL-1 inhibitors to standard options, one such drug (canakinumab) resolved flare symptoms in a median of about four days, compared to roughly eight days for an injected steroid. Another, anakinra, brought the median resolution time down to about five days versus more than eight days for placebo.3Archives of Clinical Rheumatology. Interleukin-1 Inhibitors for Acute Gout Flares: A Systematic Review and Meta-analysis In a separate case series review, over 90% of gout flares treated with anakinra showed a complete or partial response within one to three days.4PubMed Central. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature These drugs are usually reserved for people with kidney disease or other conditions that make standard treatments risky.
Why Ice Helps and Heat Makes It Worse
One of the simplest things you can do for gout swelling is apply ice, and one of the worst things you can do is apply heat. A study comparing cold and hot compresses in patients with gouty arthritis found a striking difference: the cold compress group saw joint circumference decrease by about 25% over five days, while the hot compress group saw almost no improvement, only about a 5% decrease, and in some patients swelling actually got worse after heat was applied.5PubMed Central. Data Insights on the Risks of Local Heat and Massage in Gouty Arthritis Treatment This makes physiological sense: gout is driven by an intense inflammatory reaction to urate crystals, and heat increases blood flow and inflammatory activity in the area. Cold does the opposite, constricting blood vessels and dampening the local inflammatory cascade.
If you’re icing a gout flare, wrap the ice pack in a cloth and apply it for about 20 minutes at a time. Don’t use it directly on the skin, and don’t leave it on indefinitely. Elevation of the affected joint also helps by encouraging fluid drainage away from the swollen area. These measures won’t replace medication for a severe flare, but they meaningfully accelerate swelling reduction alongside drug treatment.
Why Gout Flares Tend to Strike at Night
If your gout flare woke you up at 2 a.m., you’re not imagining a pattern. Gout attacks are significantly more likely to begin during late-night and early-morning hours. Several overlapping factors explain this. Body temperature dips to its lowest point between roughly 2 a.m. and 6 a.m., and cooler temperatures make uric acid more likely to crystallize in joint fluid. Relative dehydration during sleep concentrates uric acid in the blood and joints. And cortisol, the body’s natural anti-inflammatory hormone, bottoms out around midnight to 4 a.m., removing one of the brakes on inflammation.6PubMed Central. Nocturnal Risk of Gout Attacks
Beyond those factors, the molecular machinery that drives gout inflammation, specifically the NLRP3 inflammasome, is itself under circadian control. Macrophages, the immune cells that react to urate crystals, show time-of-day differences in how readily they activate this inflammatory pathway. Exposure to urate crystals appears to disrupt the normal circadian suppression of inflammasome activity, creating windows of heightened vulnerability during nighttime hours.7Gout, Urate, and Crystal Deposition Disease. Circadian Rhythms in NLRP3 Inflammasome Regulation: Possible Implications for the Nighttime Risk of Gout Flares This is relevant to swelling timelines because it means most people discover a flare in the morning when it has already been building for hours. Starting treatment as soon as you notice symptoms is the single most effective way to shorten the attack.
The Inflammation Underneath the Swelling
What makes gout swelling so dramatic compared to, say, a sprained ankle is the ferocity of the immune response. When urate crystals form in a joint, the body treats them like an invading pathogen. Macrophages engulf the crystals and activate the inflammasome, triggering a cascade of inflammatory signaling that draws more immune cells into the area. The resulting flood of inflammatory molecules, fluid, and immune cells produces the intense redness, heat, and swelling that characterize a gout flare.
Recent research has revealed that the resolution of this response isn’t just the immune system burning itself out. Specific cell types actively shut the inflammation down. For example, experiments have shown that CD8 T cells expressing a protein called perforin help regulate macrophage-driven inflammation. When perforin is absent, swelling becomes more severe and prolonged, with greater accumulation of inflammatory cells and higher levels of the pro-inflammatory signal TNF-alpha.8PubMed. CD8 T cell-derived perforin regulates macrophage-mediated inflammation in a murine model of gout This helps explain why some people’s flares resolve briskly while others seem to drag on: the resolution phase is an active process, not just the fading of inflammation, and individual differences in immune regulation affect how quickly it happens.
When Swelling Doesn’t Resolve in the Expected Window
If your swelling hasn’t improved after two weeks of appropriate treatment, something else may be going on. There are a few possibilities worth knowing about.
The first is that the flare is more severe than typical. People with long-standing gout, those who have heavy crystal deposits in their joints, or those who delayed treatment can have flares that last three weeks or longer. This is particularly common when multiple joints are involved simultaneously. The inflammatory burden is simply greater, and the immune system takes longer to shut it down.
The second, more concerning possibility, is joint infection. Septic arthritis can look nearly identical to a gout flare: marked swelling, redness, heat, pain, and even fever. The overlap is so strong that the presence of urate crystals in joint fluid does not rule out infection, because the septic process itself can shake crystals loose from cartilage or the joint lining.9PubMed Central. Septic Arthritis Complicating a Gout Flare: Report of Two Cases and Review of the Literature If you have a fever alongside a flare that isn’t responding to treatment, or if the joint is getting worse rather than better after 48 hours, get medical attention promptly. Septic arthritis left untreated can permanently damage the joint.
A third possibility is that what looks like persistent swelling is actually tophaceous gout, where solid deposits of urate have accumulated in or around the joint over years. Tophi cause a more chronic, lumpy swelling that won’t go away with anti-inflammatory treatment alone, because the swelling isn’t just inflammation but physical masses of crystallized urate.
Tophi and the Much Longer Timeline
Tophi represent gout that has been undertreated or untreated for years. Dissolving these deposits requires sustained urate-lowering therapy, and the timeline is measured in months or years, not days. In a study tracking patients on aggressive urate-lowering treatment, the mean projected time for complete tophus resolution was about 10 months, though individual cases ranged from roughly 5 to 33 months.10PubMed Central. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase The lower you can get the serum urate level and the longer you keep it there, the faster tophi shrink.
Even without visible tophi, urate crystals persist in joint fluid long after a flare has subsided. A study that tracked crystal clearance found that the time for complete disappearance ranged from 3 to 33 months after urate levels were brought into the normal range, and that clearance time correlated strongly with how long the person had had gout.11PubMed Central. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout This is a critical point for understanding why swelling recurs: even when you feel fine between flares, the crystals are still there, quietly priming the immune system for the next episode.
The Paradox of Starting Urate-Lowering Therapy
One of the most frustrating aspects of gout treatment is that starting the medication meant to prevent future flares can trigger new ones. When you begin a drug like allopurinol or febuxostat to lower uric acid levels, the shifting concentration of urate in the blood can destabilize existing crystal deposits, provoking fresh inflammation. This “mobilization flare” is a well-known phenomenon, and it’s one reason doctors co-prescribe low-dose colchicine or another anti-inflammatory during the first months of urate-lowering therapy.
How you start the medication matters. A trial comparing ultra-low starting doses of febuxostat with standard doses found that the ultra-low approach cut flare rates roughly in half over 24 weeks, with 70% of patients in the gradual-start group remaining completely flare-free compared to under half in the standard group.12PubMed Central. Efficacy and Safety of Ultra‐Low Starting Dose Febuxostat Titration in Male Patients With Primary Gout The principle is “start low, go slow.” A slower dose escalation means a more gradual drop in uric acid, which destabilizes fewer crystals at once and results in fewer and milder flares during the transition period.
The prophylactic landscape is also evolving. An early-phase trial of firsekibart, an experimental biologic that blocks IL-1 signaling, found that a single injection virtually eliminated flares during the first 12 weeks of urate-lowering therapy. None of the participants receiving the higher dose experienced any flares at all, compared to about 22% of those on daily colchicine.13PubMed Central. Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate‐Lowering Therapy This is still in clinical development, but it illustrates how much room for improvement exists beyond the current standard approach.
Weight Loss, Diet, and Flare Frequency
You’ll find no shortage of advice about dietary changes for gout, from avoiding red meat to cutting alcohol to drinking cherry juice. The evidence on weight loss specifically is mixed in a way that surprises most people. A systematic review of weight-loss studies in people with gout found that six out of eight studies showed beneficial effects on flare frequency over time.14PubMed Central. Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies But there’s an important wrinkle: in the short term, rapid weight loss, especially after bariatric surgery, can temporarily increase uric acid levels and actually provoke flares. The body releases stored purines from breaking-down tissue, which gets converted to uric acid.
A randomized trial testing a structured low-energy diet for people with gout and obesity found that while the diet group lost significantly more weight (about 15 kg versus 8 kg over 16 weeks), there was no measurable difference in pain, gout flares, or uric acid levels between the groups during that period.15PubMed. Weight Loss for Patients With Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial The long-term trajectory still favors weight loss for reducing flares, but if you’re hoping that dropping 10 pounds will immediately make your current swelling go down faster, the evidence doesn’t support that expectation. Weight management is a long game for gout, not an acute treatment.
The Real-World Impact of Repeated Swelling
Gout flares aren’t just painful episodes that you ride out and forget. For people with chronic refractory gout, the functional toll is substantial. In a study of patients with treatment-resistant gout, 78% of those under 65 reported missing at least one work day due to a gout attack in the previous year, with an average of 25 lost work days annually. The impact extended beyond employment: patients reported losing an average of 17 days of social activity and nearly 17 days of impaired self-care per year.16PubMed. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy These numbers come from a severe-gout population, but they underscore something important: each flare isn’t just a few days of limping. Repeated swelling that takes a week or more to resolve each time adds up to weeks or months of functional limitation per year.
This is part of why rheumatologists push hard for urate-lowering therapy even when patients feel fine between attacks. The goal isn’t just to treat the flare you’re having now but to dissolve the crystal deposits that guarantee future ones. Once uric acid is kept consistently below the saturation point, existing crystals slowly dissolve, flares become less frequent, and over time they can stop entirely. That process takes patience, typically a year or more of consistent treatment, but it’s the only way to address the root cause rather than just managing swelling each time it appears.
Kidney Disease and Treatment Limitations
Gout and kidney disease are deeply intertwined. The kidneys are responsible for clearing most of the body’s uric acid, so reduced kidney function means higher urate levels and more frequent flares. Complicating matters further, several of the front-line treatments for acute flares become risky or unusable as kidney function declines. NSAIDs can worsen kidney function. Colchicine doses need to be reduced and in severe kidney disease may be too dangerous to use at all. This often leaves corticosteroids as the primary option, sometimes supplemented by IL-1 inhibitors in refractory cases.17PubMed Central. Management of Patients with Gout and Kidney Disease: A Review of Available Therapies and Common Missteps
For people with moderate to severe kidney disease, swelling from gout flares may take longer to resolve simply because fewer treatment options are available at full strength. If you have both conditions, working with a rheumatologist rather than managing flares on your own becomes especially important, because the margin for error in drug selection and dosing is much narrower.
Monitoring Crystal Deposits With Imaging
One question people often have after a flare resolves is whether the crystals are still there. The answer is almost certainly yes if you haven’t been on sustained urate-lowering therapy. Ultrasound has emerged as a practical way to track crystal deposits in joints. It can detect urate deposits on cartilage surfaces and within soft tissue, and the findings change with treatment, making it useful for both diagnosis and monitoring.18PubMed Central. Ultrasound Features in Gout: An Overview If your doctor orders an ultrasound after a flare, they’re looking not just at current inflammation but at the overall burden of crystal deposition, which tells you something about your risk for future flares and helps guide decisions about whether and how aggressively to pursue urate-lowering therapy.
Dual-energy CT is another imaging option that can visualize urate deposits in three dimensions, but it’s more expensive and less widely available. For most patients, ultrasound during or shortly after a flare provides enough information to guide treatment without the added cost. What matters most isn’t which imaging modality is used but whether anyone is looking at the bigger picture: a flare that resolves in a week is good news, but if the underlying crystal load is heavy, the next flare is already being set up.